XML 36 R24.htm IDEA: XBRL DOCUMENT

Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023	Sep. 11, 2020
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Capital stock issued (in Shares)						7,500,000
Capital stock outstanding (in Shares)						7,500,000
Research and development	$ 2,763,865	$ 3,764,675	$ 8,991,673	$ 11,937,045
Goodwill	$ 9,346,796		9,346,796		$ 9,346,796
Delaware Corporation [Member]
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Ownership, percentage						75.00%
Leonard Meron Biosciences Inc [Member]
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Research and development			19,400,000
In Process Research and Development [Member]
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Research and development			$ 40,000,000
Revenue generation term			12 years
In Process Research and Development [Member] \| Subsidiaries [Member]
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies [Line Items]
Revenue generation term			8 years